GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024.
- Revenue
- +7.19%
- EPS
- +40.6%
- Free cash flow
- +64.2%
- Total debt
- −1.90%
Quarter to September 2026, against a year earlier
Follow GEHC
Alert me
GE HealthCare Technologies Inc. (GEHC) EV/EBITDA
As of 5 November 2026, GE HealthCare Technologies Inc. (GEHC) trades at a EV/EBITDA of 13.2×. Over the past ten years it has ranged from 0.0× (December 2022) to 16.8× (March 2024); the current reading is higher than 52% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 13.3× | (1.10%) |
| FY2024 | 13.5× | (4.93%) |
| FY2023 | 14.2× | 38.90% |
| FY2022 | 10.2× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 10.9× | (5.08%) |
| Jun 2026 | 11.5× | (10.61%) |
| Mar 2026 | 12.9× | (3.59%) |
| Dec 2025 | 13.3× | 4.97% |
| 15 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| GKOS Glaukos Corporation compare | n/m |
| SNN Smith & Nephew SNATS, Inc. compare | 6.5× |
| PHG Koninklijke Philips N.V. compare | 11.1× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 12.1× |
| GEHC GE HealthCare Technologies Inc. | 13.2× |
| BSX Boston Scientific Corporation compare | 14.0× |
| STE STERIS plc compare | 15.7× |
| DXCM DexCom, Inc. compare | 21.2× |
| EW Edwards Lifesciences Corporation compare | 34.0× |
| Medical Devices industry median | 11.5× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on GEHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement